Creatine plays a central role in cellular energy buffering. Cells rely on ATP for repair, signalling, and structural maintenance — processes that are often compromised during and after intensive cancer treatment.
In oncology settings, creatine is commonly used to support:
Energy availability in metabolically stressed tissues
Muscle preservation during periods of weight loss or inactivity
Neuromuscular function and resilience
General recovery capacity
Nerve repair and muscle maintenance are both energy-dependent processes. When ATP availability is low, recovery slows. Creatine helps stabilise energy supply within cells, supporting the metabolic conditions required for repair and functional stability.
This is supportive care, not a primary cancer treatment, and is best used as part of a structured integrative plan.